ORIC Pharmaceuticals Inc. Tech Stack
Clinical-stage oncology company developing PRC2 and EGFR inhibitors
ORIC is a clinical-stage biopharmaceutical company with two lead candidates in prostate and lung cancer indications. The hiring mix is heavily regulatory and quality-focused—VP and director roles in regulatory affairs, CMC, and quality dominate the recent openings—indicating a company preparing for regulatory submissions and eventual commercialization. Tech stack reflects typical pharma infrastructure (Veeva Vault for document/regulatory management, NetSuite for financial operations, SAS for data analysis), with active adoption of Veeva Vault signaling investment in compliance-ready systems.
Tech Stack 12 technologies
What ORIC Pharmaceuticals Inc. Is Building
◆Challenges
- Launch readiness and life cycle management
- Global safety regulation compliance
- Timely regulatory submissions
- Scalable compliant enterprise applications
- Efficient regulatory pathway
- Public company compliance
- Compliance with 21 cfr part 11
- Preparing for health authority inspections
- Data discoverability and interoperability
- Regulatory risk mitigation
▲Active Projects
- Global regulatory strategy development
- Rinzimetostat medical strategy
- Safety management plan development
- Application architecture design
- Multi-year enterprise applications roadmap
- Internal systems for regulatory submissions
- Digital transformation of development systems
- Gdpr compliance program
- Regulatory submission strategy
- Manufacturing change impact assessment
Hiring Activity
Department
Seniority
Notable leadership hires: Regulatory Affairs VP, CMC Regulatory Affairs Director, Director Quality
